Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2013
10/03/2013US20130261134 Mesylate salt forms of a potent hcv inhibitor
10/03/2013US20130261120 Substituted n-(2-arylamino)aryl sulfonamide-containing combinations
10/03/2013US20130261116 Novel 3,5-disubstituted-3h-imidazo[4,5-b]pyridine and 3,5-disubstituted -3h-[1,2,3]triazolo[4,5-b] pyridine compounds as modulators of protein kinases
10/03/2013US20130261114 Compounds useful as inhibitors of choline kinase
10/03/2013US20130261108 Compositions and methods for modulating farnesoid x receptors
10/03/2013US20130261104 Methods of use of diazacarbazoles for treating cancer
10/03/2013US20130261103 Pyridazinones, method of making, and method of use thereof
10/03/2013US20130261092 Method of synergistically enhancing the therapeutic efficacy and safety of medication through a combination therapy
10/03/2013US20130261078 Compositions of novel carbohydrate drug for treatment of human diseases
10/03/2013US20130261076 Administration of eritoran or pharmaceutically acceptable salts thereof to treat orthomyxovirus infections
10/03/2013US20130261064 N-carboxyalkyl-auristatin and the use thereof
10/03/2013US20130261045 Green tea polyphenol alpha secretase enhancers and methods of use
10/03/2013US20130259956 Pharmaceutical Kit for Treating Neuronal Damages
10/03/2013US20130259940 Tamper resistant dosage forms
10/03/2013US20130259934 Implantable tizanidine compositions and methods of treatment thereof
10/03/2013US20130259932 Controlled release formulations of levodopa and uses thereof
10/03/2013US20130259930 Compositions and Methods for Preventing and Treating Mucositis and Weight Loss
10/03/2013US20130259929 Use of a phosphopeptide able to block her3/p85 interaction for the treatment of her2 hyper-expressing tumours
10/03/2013US20130259925 METHODS AND COMPOSITIONS TO TREAT CANCER USING BIFUNCTIONAL SRC 3 shRNA
10/03/2013US20130259908 Micro-RNA Family that Modulates Fibrosis and Uses Thereof
10/03/2013US20130259897 Crystalline forms of (r)-3-[n-(3'-chlorobiphenyl-4-ylmethyl)-n'-(3-hydroxyisoxazole-5-carbonyl)hydrazino]-2-hydroxypropionic acid isopropyl ester
10/03/2013US20130259875 Acth for treatment of amyotrophic lateral sclerosis
10/03/2013US20130259873 Methods for treating a tumor using an antibody that specifically binds hmw-maa
10/03/2013US20130259871 Human Monoclonal Antibody with Specificity for Dengue Virus Serotype 1 E Protein and Uses Thereof
10/03/2013US20130259870 Galactomannan polysaccharide composition for the treatment of nonalcoholic steatohepatitis and nonalcoholic fatty liver disease
10/03/2013US20130259859 Ang2-binding molecules
10/03/2013US20130259856 Treatment of multiple sclerosis with combination of laquinimod and dimethyl fumarate
10/03/2013US20130259852 Lysozyme gel formulations
10/03/2013US20130259850 Compounds and method for reducing uric acid
10/03/2013US20130259845 Treatment of premature birth complications
10/03/2013US20130259832 Combinations of Hepatitis C Virus Inhibitors
10/03/2013US20130259831 3,5-Disubstituted and 3,5,7-Trisubstituted-3H-Oxazolo and 3H-Thiazolo[4,5-d]pyrimidin-2-one Compounds and Prodrugs Thereof
10/03/2013US20130259830 Crth2 modulators
10/03/2013US20130259826 Compositions, methods and uses for stimulating immune responses
10/03/2013US20130259799 Human gm-csf antigen binding proteins
10/03/2013CA2875200A1 Fibrosis suppression by inhibiting integrin alpha8beta1 function
10/02/2013EP2644204A2 Combinations of an anti-HER2 antibody-drug conjugate and pertuzumab
10/02/2013EP2644199A1 Methods for detecting and modulating the sensitivity of tumour cells to anti-mitotic agents
10/02/2013EP2643320A1 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
10/02/2013EP2643007A2 Pharmaceutical composition comprising extract of lonicera japonica for prevention and treatment of gastroesophageal reflux disease
10/02/2013EP2643006A1 Oligosaccharide composition for treating acute respiratory tract infections
10/02/2013EP2643005A1 Composition comprising hydrolysed proteins and oligosaccharides for treating skin diseases
10/02/2013EP2643004A1 Oligosaccharide composition for treating skin diseases
10/02/2013EP2643003A1 Vaginal composition based on alkyl polyglucosides
10/02/2013EP2642978A2 Immunomodulatory compositions comprising hydralazine for the treatment of gastrointestinal disorders
10/02/2013EP2642859A2 Method of treating neurological conditions with extract of nerium species or thevetia species
10/02/2013EP2484365B1 Compositions and method for treatment of neovascular diseases
10/02/2013CN103330940A Combined preparation and application of combined preparation in preparing non-small-cell lung carcinoma drug
10/02/2013CN103330939A Combined use of dipeptidyl peptidase iv inhibitor compound and sweetener
10/02/2013CN102641501B Application of NALP3-ASC inflammation complex and activator inhibitor thereof in terms of preparation of medicines for treating prion diseases
10/02/2013CN101679251B (Aza)indole derivative and use thereof for medical purposes
10/01/2013US8545843 Treatment of vasculitis
10/01/2013US8545830 Smart segment and a hydrophobic and a hydrophillic biodegradable segment which are hydrolytically or enzymatically degradable; prolonged delivery of therapeutic agents
10/01/2013CA2750626C High dosage doramectin formulation
10/01/2013CA2730715C Antineoplastic combinations of 4-anilino-3-cyanoquinolines and capecitabine
10/01/2013CA2689741C Latent human tuberculosis model, diagnostic antigens, and methods of use
10/01/2013CA2644143C Combinations comprising bcr-abl/c-kit/pdgf-r tk inhibitors for treating cancer
10/01/2013CA2594482C Antitumor agent
10/01/2013CA2566161C Aryl ketone compounds and compositions for delivering active agents
10/01/2013CA2479835C An ephrin-b receptor protein involved in carcinoma
10/01/2013CA2467689C Stabilization of hypoxia inducible factor (hif) alpha using inhibitors of hif prolyl hydroxylase
10/01/2013CA2454873C Novel transformed cell, method for screening anti-aging agent, and anti-aging agent
10/01/2013CA2239448C Blockade of t lymphocyte down-regulation associated with ctla-4 signaling
09/2013
09/26/2013WO2013142875A1 Treatment of brain cancer
09/26/2013WO2013142427A1 Compounds and methods for kinase modulation, and indications therefor
09/26/2013WO2013142258A1 Compositions and methods for oral delivery of encapsulated diethylenetriaminepentaacetate particles
09/26/2013WO2013141202A1 Muscle-building agent and screening method for muscle-building substance
09/26/2013WO2013140372A1 Method for treating gynecological diseases
09/26/2013WO2013139941A1 Pharmaceutical combination products for parkinson's disease
09/26/2013WO2013139724A1 Combination therapy (vemrufenib and a mdm2 inhibitor) for the treatment proliferative disorders
09/26/2013WO2013138909A1 Detection and modulation of rheumatoid arthritis
09/26/2013WO2013073454A3 Controlled release composition for physiologically active substance
09/26/2013US20130253052 Anti-cancer compositions and methods
09/26/2013US20130253047 Method and composition for preventing and treating avian influenza in poultry
09/26/2013US20130253046 Methods of treating cancer comprising targeting nqo1
09/26/2013US20130253029 Novel bicyclic compounds
09/26/2013US20130253005 Small molecule inhibitors of usp1 deubiquitinating enzyme activity
09/26/2013US20130253000 Treatment of solid tumors with rapamycin derivatives
09/26/2013US20130252993 Tricyclic compound and use thereof
09/26/2013US20130252990 Stable pharmaceutical composition and methods of using same
09/26/2013US20130252989 Stable pharmaceutical composition and methods of using same
09/26/2013US20130252979 Pharmaceutical compositions, dosage forms and new forms of the compound of mula (i), and methods of use thereof
09/26/2013US20130252965 Combinations of serotonin receptor agonists for treatment of movement disorders
09/26/2013US20130252955 (aza)indole derivative and use thereof for medical purposes
09/26/2013US20130252952 1,2,4-TRIAZOLO[4,3-a]PYRIDINE DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF MGLUR2 RECEPTORS
09/26/2013US20130252947 BMP-2 Upregulating Compounds For Healing Bone Tissue And Screening Methods For Selecting Such Compounds
09/26/2013US20130252944 Novel fused pyrazole derivatives and their use as allosteric modulators of metabotropic glutamate receptors
09/26/2013US20130252942 Quinazoline carboxamide azetidines
09/26/2013US20130252937 New indanyloxydihydrobenzofuranylacetic acids
09/26/2013US20130252934 Serine/threonine kinase inhibitors
09/26/2013US20130252928 Combinations comprising antimuscarinic agents and pde4 inhibitors
09/26/2013US20130252925 Pain relief compositions, manufacture and uses
09/26/2013US20130252922 Substituted phenoxypyridines
09/26/2013US20130252911 Compositions comprising flavonoid-containing extracts from plants of the genus citrus and/or isolated citrus flavonoids and specific cationic surface active agents, and said composition for use as an agent for treating infestations with head lice
09/26/2013US20130252908 Pharmaceutical composition, methods for treating and uses thereof
09/26/2013US20130252907 Small Peptides And Methods For Blocking IgE Mediated Activation Of An Immune Cell
09/26/2013US20130252889 Composition comprising vlp and amyloid beta peptide
09/26/2013US20130252885 Fused tricyclic compounds as adenosine receptor antagonist
09/26/2013US20130252883 Macrocycles and Their Uses
09/26/2013US20130251821 Vegf-activated fas ligands
1 ... 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 ... 1151